IP Library Granted Patent US 8,795,960
Granted Patent B2
US 8,795,960 · App. 12/480,215 · Granted Aug 5, 2014

Optimization of gene expression analysis using immobilized capture probes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,795,960
App. No.
12/480,215
Granted
Aug 5, 2014
Kind
B2
Abstract

Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including: methods of probe and target “engineering”, as well as methods of assay signal analysis relating to the modulation of the probe-target affinity constant, K by a variety of factors including the elastic properties of target strands and layers of immobilized (“grafted”) probes; and assay methodologies relating to: the tuning of assay signal intensities including dynamic range compression and on-chip signal amplification; the combination of hybridization-mediated and elongation-mediated detection for the quantitative determination of abundance of messages displaying a high degree of sequence similarity, including, for example, the simultaneous determination of the relative expression levels, and identification of the specific class of, untranslated AU-rich subsequences located near the 3′ terminus of mRNA; and a new method of subtractive differential gene expression analysis which requires only a single color label.

Claims (16)

1. A method comprising:

a) Providing a sample;

b) Providing probe reagents complementary to a target polynucleotide in the sample;

c) Estimating the concentration of the target in the sample;

d) Adjusting the affinity constant (K) governing the interaction of the target with the probe reagents by:

i. using short target length when the target is anticipated to be present in low concentration; or

ii. using long target length when the target is anticipated to be present in high concentration; wherein the relationship between target length (I) and K is: K=al x : wherein a is a constant and x<0; and

e) Quantifying the target using one or more probe reagents.

2. The method of claim 1 wherein the target polynucleotide is a cDNA produced from a corresponding mRNA by reverse transcription and target length is adjusted by adjusting the placement of a reverse transcription primer on the mRNA.

3. The method of claim of 2 , wherein said primer is placed towards the 5′ terminus of the mRNA.

4. The method of claim 2 , wherein said primer is placed adjacent to the 5 ′ terminus of the mRNA.

5. The method of claim 1 , wherein quantification occurs directly or following an in-vitro nucleic acid amplification reaction.

6. The method of claim 1 , wherein said short target length is less than about 150 nucleotides.

7. The method of claim 1 , wherein said long target length is more than about 150 nucleotides.

8. The method of claim 1 , wherein said probe reagents comprise microparticles.

9. The method of claim 8 , wherein said microparticles are encoded.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2011
From: SEUL, MICHAEL; VENER, TATIANA; BANERJEE, SUKANTA; YANG, JIACHENG
To: BIOARRAY SOLUTIONS LTD
Reel/Frame 026928/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2011
From: SEUL, MICHAEL; BANERJEE, SUKANTA; YANG, JIACHENG; VENER, TATIANA
To: BIOARRAY SOLUTIONS LTD
Reel/Frame 026913/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2011
From: SEUL, MICHAEL; BANERJEE, SUKANTA; YANG, JIACHENG; VENER, TATIANA
To: BIOARRAY SOLUTIONS LTD
Reel/Frame 026913/0682 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2011
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026778/0640 →